Maravai LifeSciences Aktie News

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Maravai LifeSciences To Contact Him Directly To Discuss Their Options

Maravai LifeSciences Holdings, Inc. (NASDAQ:MRVI ) Q4 2024 Earnings Conference Call March 20, 2025 5:00 PM ET Company Participants Deb Hart - Head, IR Kevin Herde - EVP and CFO Trey Martin - CEO Conference Call Participants Matt Stanton - Jeffries Doug Schenkel - Wolfe Research Matt Larew - William Blair Ricki Levitus - Guggenheim Tejas Savant - Morgan Stanley Dan Arias - Stifel Catherine Schul...

NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Maravai LifeSciences Holdings, Inc. (NASDAQ: MRVI).

WASHINGTON, DC / ACCESS Newswire / March 20, 2025 / Investors in Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ:MRVI) are encouraged to take action if they purchased shares between August 7, 2024, and February 24, 2025 (the "Class Period") and suffered losses. A securities class action lawsuit has been filed against the Company, and the deadline to petition for lead pl...

Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses In Maravai LifeSciences To Contact Him Directly To Discuss Their Options NEW YORK CITY, NY / ACCESS Newswire / March 20, 2025 / If purchased or acquired securities in Maravai LifeSciences between August 7, 2024 and February 24, 2025 and would like to discuss your legal rights, call Fa...

NEW YORK , March 19, 2025 /PRNewswire/ --  Why: Rosen Law Firm, a global investor rights law firm, reminds of purchasers of securities of Maravai Lifesciences Holdings, Inc. (NASDAQ: MRVI) between August 7, 2024 and February 24, 2025, both dates inclusive (the "Class Period"), of the important May 5, 2025 lead plaintiff deadline. So what: If you purchased Maravai securities during the Class Per...

LOS ANGELES , March 19, 2025 /PRNewswire/ --  Glancy Prongay & Murray LLP announces that investors with losses have opportunity to lead the securities fraud class action lawsuit against Maravai LifeSciences Holdings, Inc. ("Maravai" or the "Company") (NASDAQ: MRVI). IF YOU SUFFERED A LOSS ON YOUR MARAVAI INVESTMENTS, CLICK HERE BEFORE MAY 5, 2025 (LEAD PLAINTIFF DEADLINE) TO PARTICIPATE IN THE ...

SAN DIEGO, March 18, 2025 (GLOBE NEWSWIRE) -- Maravai LifeSciences Holdings, Inc. (Maravai) (NASDAQ: MRVI), a global provider of life science reagents and services to researchers and biotech innovators, today reported financial results for the fourth quarter and full year ended December 31, 2024, together with other business updates. The company also expects to file its Annual Report on Form 10...